http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-0206650-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7f6e33603375c486b0ab3505830af9e8
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4985
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04
filingDate 2002-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c72407fce616fbe3148bc3c07d5a9427
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9eacfbd081e0faca1103d71621f86543
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3690c539008df0933afa0409b64ee0ed
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cf2a2148b6ccdba0977e0b86a7034afd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e9f708d24ad2321e4da78b0cbbb3810a
publicationDate 2004-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber BR-0206650-A
titleOfInvention Compound, pharmaceutical composition, use of at least one compound, and process for preparing a compound
abstract "COMPOUND, PHARMACEUTICAL COMPOSITION, USE OF AT LEAST ONE COMPOUND, AND PROCESS FOR PREPARING A COMPOUND". Compounds of formula (I): wherein: A is a pyrrol ring; R4 is an optionally substituted aryl or heteroaryl group; R 2 is a optionally substituted nitrogen-containing heteroaryl group; and R3 is formulas (IIa), (IIb) or (IIc), wherein m is 1 or 2, one of D and E is nitrogen and the other> C (R5-5) - (where R ^ 5 ^ is hydrogen, a <244> substituent or a <225> substituent, B is a 4-7 membered nitrogen-containing heterocyclic ring, and R ^ 4 ^ is 1 to 3 substituents of the <244> substituent group , Substituent group <225> and substituent group <sym>, provided that R1 and R3 are attached to the two atoms of said pyrrole ring which are adjacent to the atom of the pyrrole ring to which said substituent R2 is. substituent group <244> consists of hydroxyl, nitro, cyano, halogen, alkoxy, halogen alkoxy, alkylthio and halogen alkylthio groups and groups of the formula -NR4a ^ R4B4 (where R4a4 and R4) (are hydrogen, alkyl, alkenyl, alkynyl, aralkyl and alkylsulfonyl, or R4a and R4b4 together with the nitrogen atom to which they are attached form a heterocyclyl); of alkyl, alkenyl groups and optionally substituted alkynyl, and aralkyl and cycloalkyl groups; <sym> substituent group consisting of oxo, hydroxyimino, alkoxyimino, alkylene, alkylenedioxy, alkylsulfinyl, alkylsulfonyl, optionally substituted aryl, optionally substituted aryloxy, alkylidenyl and aralkylidenyl groups exhibit excellent activity against the production of inflammatory cytokines.
priorityDate 2001-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419579030
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556970
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410031093
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454973655
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID222
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8027
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458427722
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457655803
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID947

Total number of triples: 32.